Literature DB >> 22577974

Submerged cultivation of medicinal mushrooms: bioprocesses and products (review).

Vladimir Elisashvili1.   

Abstract

Medicinal mushrooms belonging to higher Basidiomycetes are an immensely rich yet largely untapped resource of useful, easily accessible, natural compounds with various biological activities that may promote human well-being. The medicinal properties are found in various cellular components and secondary metabolites (polysaccharides, proteins and their complexes, phenolic compounds, polyketides, triterpenoids, steroids, alkaloids, nucleotides, etc.), which have been isolated and identified from the fruiting bodies, culture mycelium, and culture broth of mushrooms. Some of these compounds have cholesterol-lowering, anti-diabetic, antioxidant, antitumor, immunomodulating, antimicrobial, and antiviral activities ready for industrial trials and further commercialization, while others are in various stages of development. Recently, the submerged cultivation of medicinal mushrooms has received a great deal of attention as a promising and reproducible alternative for the efficient production of mushroom mycelium and metabolites. Submerged cultivation of mushrooms has significant industrial potential, but its success on a commercial scale depends on increasing product yields and development of novel production systems that address the problems associated with this technique of mushroom cultivation. In spite of many researchers' efforts for the production of bioactive metabolites by mushrooms, the physiological and engineering aspects of submerged cultures are still far from being thoroughly studied. The vast majority of studies have focused on polysaccharide and ganoderic acid production in submerged cultivation of medicinal mushrooms, and very little has been written so far on the antioxidant and hemagglutinating activity of submerged mushroom cultures. The purpose of this review is to provide an update of the present state of the art and future prospects of submerged cultivation of medicinal mushrooms to produce mycelium and bioactive metabolites, and to make a contribution for the research and development of new pharmaceutical products from mushrooms. A brief overview of the metabolic diversity and bioactive compounds of mushrooms produced by submerged cultures is also given.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577974     DOI: 10.1615/intjmedmushr.v14.i3.10

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  23 in total

1.  Sesquiterpene Synthase-3-Hydroxy-3-Methylglutaryl Coenzyme A Synthase Fusion Protein Responsible for Hirsutene Biosynthesis in Stereum hirsutum.

Authors:  Christopher M Flynn; Claudia Schmidt-Dannert
Journal:  Appl Environ Microbiol       Date:  2018-05-17       Impact factor: 4.792

2.  Comparative nutritional and mycochemical contents, biological activities and LC/MS screening of tuber from new recipe cultivation technique with wild type tuber of tiger's milk mushroom of species Lignosus rhinocerus.

Authors:  Nor Azreen Mohd Jamil; Noraswati Mohd Nor Rashid; Mohamad Hasril Abd Hamid; Norasfaliza Rahmad; Jameel R Al-Obaidi
Journal:  World J Microbiol Biotechnol       Date:  2017-12-04       Impact factor: 3.312

3.  A comparative overview of antioxidative properties and phenolic profiles of different fungal origins: fruiting bodies and submerged cultures of Coprinus comatus and Coprinellus truncorum.

Authors:  Kristina Tešanović; Boris Pejin; Filip Šibul; Milan Matavulj; Milena Rašeta; Ljiljana Janjušević; Maja Karaman
Journal:  J Food Sci Technol       Date:  2017-01-30       Impact factor: 2.701

4.  First two mitochondrial genomes for the order Filobasidiales reveal novel gene rearrangements and intron dynamics of Tremellomycetes.

Authors:  Qiang Li; Zhijie Bao; Ke Tang; Huiyu Feng; Wenying Tu; Lijiao Li; Yunlei Han; Mei Cao; Changsong Zhao
Journal:  IMA Fungus       Date:  2022-05-02       Impact factor: 8.044

5.  Genome of Diaporthe sp. provides insights into the potential inter-phylum transfer of a fungal sesquiterpenoid biosynthetic pathway.

Authors:  Jose Guedes de Sena Filho; Maureen B Quin; Daniel J Spakowicz; Jeffrey J Shaw; Kaury Kucera; Brian Dunican; Scott A Strobel; Claudia Schmidt-Dannert
Journal:  Fungal Biol       Date:  2016-04-12

Review 6.  Traversing the fungal terpenome.

Authors:  Maureen B Quin; Christopher M Flynn; Claudia Schmidt-Dannert
Journal:  Nat Prod Rep       Date:  2014-10       Impact factor: 13.423

Review 7.  A critical review on submerged production of mushroom and their bioactive metabolites.

Authors:  Umera Tasleem Dudekula; Kruthi Doriya; Santhosh Kumar Devarai
Journal:  3 Biotech       Date:  2020-07-08       Impact factor: 2.406

8.  Mushroom hunting by using bioinformatics: application of a predictive framework facilitates the selective identification of sesquiterpene synthases in basidiomycota.

Authors:  Maureen B Quin; Christopher M Flynn; Grayson T Wawrzyn; Swati Choudhary; Claudia Schmidt-Dannert
Journal:  Chembiochem       Date:  2013-10-24       Impact factor: 3.164

9.  Conservation of the mycelia of the medicinal mushroom Humphreya coffeata (Berk.) Stey. in sterile distilled water.

Authors:  Monserrat García-García; Leticia Rocha-Zavaleta; Norma A Valdez-Cruz; Mauricio A Trujillo-Roldán
Journal:  MethodsX       Date:  2014-05-09

10.  Hypolipidaemic Effect of Hericium erinaceum Grown in Artemisia capillaris on Obese Rats.

Authors:  Won-Sik Choi; Young-Sun Kim; Byeoung-Soo Park; Jang-Eok Kim; Sung-Eun Lee
Journal:  Mycobiology       Date:  2013-06-30       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.